Biomarkers in Dementia

Biomarkers in Dementia Photo

Experts believe that biomarkers offer most promising paths to diagnose Alzheimer’s or dementia. A biomarker is something that can reliably indicate the presence of disease.

Certain possible biomarkers are being studied for their strength to indicate initial stages of Dementia or Alzheimer's disease such as including beta-amyloid and tau levels in cerebrospinal fluid (CSF) and brain changes detectable by imaging. However, three biomarkers have been well-established and validated internationally to diagnose AD in CSF with ELISAs: ?-amyloid (1–42) [A? (1–42)], total tau and phospho-tau-181.


  • Cerebrospinal Fluid Biomarkers
  • Beta-amyloid & tau Biomarkers
  • Blood- Based Biomarkers
  • Neurofilament light protein Biomarkers
  • Tar-DNA binding protein-43
  • Pittsburgh compound B (PIB) Radiotracer
  • Novel approaches in Biomarkers
  • Amyloid Neuroimaging & Biomarkers
  • Morphological AD markers
  • Cerebrospinal Fluid Biomarkers
  • Beta-amyloid & tau Biomarkers
  • Blood- Based Biomarkers
  • Neurofilament light protein Biomarkers
  • Tar-DNA binding protein-43
  • Pittsburgh compound B (PIB) Radiotracer
  • Novel approaches in Biomarkers
  • Amyloid Neuroimaging & Biomarkers
  • Morphological AD markers

Are you interested in

Mail us at

Drop us a mail program enquiry
dementiacare@alliedconferences.org
Sponser/Exhibiting/advertising
dementiacare@alliedconferences.org
General queries
dementiacare@alliedconference.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.